Genetic Variation in CRHR1 is Associated with Short-Term Respiratory Response to Corticosteroids in Preterm Infants at risk for Bronchopulmonary Dysplasia

[1]  L. Doyle,et al.  Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. , 2017, The Cochrane database of systematic reviews.

[2]  L. Palermo,et al.  The Randomized, Controlled Trial of Late Surfactant: Effects on Respiratory Outcomes at 1‐Year Corrected Age , 2017, The Journal of pediatrics.

[3]  B. Poindexter,et al.  Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012. , 2015, JAMA.

[4]  J. Thorp,et al.  Neonatal Genetic Variation in Steroid Metabolism and Key Respiratory Function Genes and Perinatal Outcomes in Single and Multiple Courses of Corticosteroids , 2015, American Journal of Perinatology.

[5]  L. Nelin,et al.  Respiratory severity score on day of life 30 is predictive of mortality and the length of mechanical ventilation in premature infants with protracted ventilation , 2015, Pediatric pulmonology.

[6]  L. Doyle,et al.  An update on the impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk of bronchopulmonary dysplasia. , 2014, The Journal of pediatrics.

[7]  H. Shin,et al.  Genome-wide association study identifies ALLC polymorphisms correlated with FEV₁ change by corticosteroid. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[8]  Jian Li,et al.  Effect of dexamethasone on intelligence and hearing in preterm infants: a meta-analysis , 2014, Neural regeneration research.

[9]  D. Béracochéa,et al.  Role of corticosteroid binding globulin in the fast actions of glucocorticoids on the brain , 2014, Steroids.

[10]  Lin Li,et al.  Preconditioning crush increases the survival rate of motor neurons after spinal root avulsion , 2014, Neural regeneration research.

[11]  R. Ward,et al.  Fluticasone propionate pharmacogenetics: CYP3A4*22 polymorphism and pediatric asthma control. , 2013, The Journal of pediatrics.

[12]  N. Iyer,et al.  Non‐invasively derived respiratory severity score and oxygenation index in ventilated newborn infants , 2013, Pediatric pulmonology.

[13]  R. Wu,et al.  Genome-wide Association Identifies the T Gene as a Novel Asthma Pharmacogenetic Locus at a Glance Commentary , 2022 .

[14]  J. Klein,et al.  Variations in CRHR1 are associated with persistent pulmonary hypertension of the newborn , 2012, Pediatric Research.

[15]  Yusuke Nakamura,et al.  Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma. , 2011, The New England journal of medicine.

[16]  M. Walsh,et al.  Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants. , 2011, American journal of respiratory and critical care medicine.

[17]  D. Postma,et al.  SERPINE1 -675 4G/5G polymorphism is associated with asthma severity and inhaled corticosteroid response , 2011, European Respiratory Journal.

[18]  A. Greenough,et al.  Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial , 2010, The Lancet.

[19]  David H. Alexander,et al.  Fast model-based estimation of ancestry in unrelated individuals. , 2009, Genome research.

[20]  B. Yoder,et al.  Time-Related Changes in Steroid Use and Bronchopulmonary Dysplasia in Preterm Infants , 2009, Pediatrics.

[21]  J. Geddes,et al.  What is a randomised controlled trial? , 2009, Epidemiologia e Psichiatria Sociale.

[22]  E. Bleecker,et al.  The glucocorticoid receptor heterocomplex gene STIP1 is associated with improved lung function in asthmatic subjects treated with inhaled corticosteroids. , 2009, The Journal of allergy and clinical immunology.

[23]  Y. Oh,et al.  Association between CRHR1 polymorphism and improved lung function in response to inhaled corticosteroid in patients with COPD , 2009, Respirology.

[24]  J. Aschner,et al.  Peptide-containing, Synthetic Surfactant for the Prevention of a Pilot Randomized, Controlled Trial of Later Treatment with a a Pilot Randomized, Controlled Trial of Later Treatment with a Peptide-containing, Synthetic Surfactant for the Prevention of Bronchopulmonary Dysplasia What's Known on This , 2022 .

[25]  K. Jang,et al.  Heritability of Bronchopulmonary Dysplasia, Defined According to the Consensus Statement of the National Institutes of Health , 2008, Pediatrics.

[26]  C. Moon,et al.  Epigenetic silencing of human T (brachyury homologue) gene in non-small-cell lung cancer. , 2008, Biochemical and biophysical research communications.

[27]  F. Schmidt.  Meta-Analysis , 2008 .

[28]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[29]  Thomas A Trikalinos,et al.  Implications of small effect sizes of individual genetic variants on the design and interpretation of genetic association studies of complex diseases. , 2006, American journal of epidemiology.

[30]  M. Walsh,et al.  Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. , 2006, The New England journal of medicine.

[31]  L. Ment,et al.  Familial and Genetic Susceptibility to Major Neonatal Morbidities in Preterm Twins , 2006, Pediatrics.

[32]  L. Katz,et al.  Repeat surfactant therapy for postsurfactant slump , 2006, Journal of Perinatology.

[33]  G. Barker,et al.  Dexamethasone dosing, mechanical ventilation and the risk of cerebral palsy , 2006, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[34]  J. Carlin,et al.  Low-Dose Dexamethasone Facilitates Extubation Among Chronically Ventilator-Dependent Infants: A Multicenter, International, Randomized, Controlled Trial , 2006, Pediatrics.

[35]  M. Walsh,et al.  Validation of the National Institutes of Health Consensus Definition of Bronchopulmonary Dysplasia , 2005, Pediatrics.

[36]  A. Sanabria,et al.  Randomized controlled trial. , 2005, World journal of surgery.

[37]  S. Gabriel,et al.  Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids. , 2004, Human molecular genetics.

[38]  C. McEvoy,et al.  Randomized, double‐blinded trial of low‐dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia , 2004, Pediatric pulmonology.

[39]  M. Walsh,et al.  Safety, Reliability, and Validity of a Physiologic Definition of Bronchopulmonary Dysplasia , 2003, Journal of Perinatology.

[40]  R. Ehrenkranz,et al.  Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. , 2003, The Cochrane database of systematic reviews.

[41]  A. Zaritsky,et al.  Early postnatal dexamethasone treatment and increased incidence of cerebral palsy , 2000, Archives of disease in childhood. Fetal and neonatal edition.

[42]  C. McEvoy,et al.  Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized, controlled trial. , 1995, Pediatrics.

[43]  K. Raivio,et al.  Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia. , 1993, Archives of disease in childhood.

[44]  M. Yoder,et al.  Effect of dexamethasone on pulmonary inflammation and pulmonary function of ventilator-dependent infants with bronchopulmonary dysplasia. , 1991, The American review of respiratory disease.

[45]  Sharon L. Wright,et al.  Randomized Trial of Late Surfactant Treatment in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide. , 2016, The Journal of pediatrics.

[46]  S. Bessman,et al.  Effect of five days of dexamethasone therapy on ventilator dependence and adrenocorticotropic hormone-stimulated cortisol concentrations. , 1997, Journal of perinatology : official journal of the California Perinatal Association.